Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes.

Devin W Steenkamp, Kathryn L Fantasia, Howard A Wolpert

Journal: Endocrinology and metabolism clinics of North America 2024;53(1):67-80

PMID: 38272599

Full Text on Elsevier Science View on PubMed

Abstract

Individuals living with type 1 diabetes (T1D) from medically underserved communities have poorer health outcomes. Efforts to improve outcomes include a focus on team-based care, activation of behavior change, and enhancing self-management skills and practices. Advanced diabetes technologies are part of the standard of care for adults with T1D. However, health care providers often carry implicit biases and may be uncomfortable with recommending technologies to patients who have traditionally been excluded from efficacy trials or have limited real-world exposure to devices. We review the literature on this topic and provide an approach to address these issues in clinical practice.

Address: Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, 72 East Concord Street, C3, Boston, MA 02118, USA. Electronic address: [email protected].; Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, 72 East Concord Street, C3, Boston, MA 02118, USA; Department of Medicine, Evans Center for Implementation and Improvement Sciences (CIIS), Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, 72 East Concord Street, C3, Boston, MA 02118, USA.

DOI: 10.1016/j.ecl.2023.07.001

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetestype1.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Humans, Diabetes Mellitus, Type 1, Medically Underserved Area